CellVoyant
CellVoyant is an AI-first biotechnology company focused on curing chronic diseases by accelerating the development of life-changing therapies. Their core technology leverages AI-first live cell imaging to predict and optimize stem cell differentiation. This enables advanced cell analytics and process development, aiming for the controllable, scaled manufacturing of any cell and tissue in the body. They operate at the intersection of cell biology, computer vision, engineering, and machine learning to industrialize scientific research. The company is backed by prominent investors, including early backers of DeepMind, Exscientia, Recursion, Automata, and Wayve, as well as the Founder and CEO of Abcam.
CellVoyant
CellVoyant is an AI-first biotechnology company focused on curing chronic diseases by accelerating the development of life-changing therapies. Their core technology leverages AI-first live cell imaging to predict and optimize stem cell differentiation. This enables advanced cell analytics and process development, aiming for the controllable, scaled manufacturing of any cell and tissue in the body. They operate at the intersection of cell biology, computer vision, engineering, and machine learning to industrialize scientific research. The company is backed by prominent investors, including early backers of DeepMind, Exscientia, Recursion, Automata, and Wayve, as well as the Founder and CEO of Abcam.